Takara Bio is a bio-technological company. Along with its subsidiaries, Co. operates in three business segments: bioindustry, gene therapy, and agribio. The Bioindustry segment provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The Gene Therapy segment develops and commercializes gene therapies for cancer and AIDS. The AgriBio segment discovers the functionality of traditional Japanese food ingredients, and develops and produces functional foods that utilize these materials. As of Mar 31 2017, Co. has 11 consolidated subsidiaries.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.